Oppenheimer & CO Inc Adial Pharmaceuticals, Inc. Transaction History

Oppenheimer & CO Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	BUY	$57.75 - $116.75 $606,375 - $1.23 Million	10,500 Added 37.5%	38,500 $165,000
Q2 2021 Aug 03, 2021	BUY	$50.5 - $78.25 $681,750 - $1.06 Million	13,500 Added 93.1%	28,000 $71,000
Q1 2021 May 10, 2021	BUY	$43.25 - $79.75 $627,125 - $1.16 Million	14,500 New	14,500 $35,000

5.5K

Ticker ADIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,854,000
Market Cap $26M
Description
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focu...

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Oppenheimer & CO Inc with notifications on news.